| 1 | [SID56422573] | Active | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 2 | [SID56422573] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID56422573] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 4 | [SID56422573] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 5 | [SID56422573] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 6 | [SID56422573] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 7 | [SID56422573] | Inactive | Potency | 3.9811 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID56422573] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID56422573] | Inactive | | | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID652136, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 652136 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID56422573] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID56422573] | Inactive | | | VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID686996, Type: screening] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 686996 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID56422573] | Inactive | | | Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity [AID2099, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity | | AID | 2099 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID56422573] | Inactive | | | uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line [AID2380, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line | | AID | 2380 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID56422573] | Inactive | IC50 | | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) [AID2391, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) | | AID | 2391 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID56422573] | Inactive | | | Small Molecules that selectively kill Giardia lamblia: qHTS [AID540267, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Small Molecules that selectively kill Giardia lamblia: qHTS | | AID | 540267 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID56422573] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID56422573] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity [AID588334, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity | | AID | 588334 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID56422573] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 19 | [SID56422573] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 20 | [SID56422573] | Inactive | | | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). [AID2235, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). | | AID | 2235 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 21 | [SID56422573] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5). [AID1987, Type: screening] | PPP5C protein [Homo sapiens] [gi:37589898] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5). | | AID | 1987 | | BioAssay type | screening | | Target | PPP5C protein [Homo sapiens] [gi:37589898] | | PubMed | | | Data Table |  |
|
| 22 | [SID56422573] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5). [AID1987, Type: screening] | PPP5C protein [Homo sapiens] [gi:37589898] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5). | | AID | 1987 | | BioAssay type | screening | | Target | PPP5C protein [Homo sapiens] [gi:37589898] | | PubMed | | | Data Table |  |
|
| 23 | [SID56422573] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 24 | [SID56422573] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 25 | [SID56422573] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 26 | [SID56422573] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 27 | [SID56422573] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 28 | [SID56422573] | Inactive | | | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID651710, Type: screening] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 651710 | | BioAssay type | screening | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 29 | [SID56422573] | Inactive | | | qHTS Assay for Inhibitors of the CtBP/E1A Interaction [AID651724, Type: screening] | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of the CtBP/E1A Interaction | | AID | 651724 | | BioAssay type | screening | | Target | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] | | PubMed | | | Data Table |  |
|
| 30 | [SID56422573] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 31 | [SID56422573] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 32 | [SID56422573] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 33 | [SID56422573] | Inactive | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | S100A4 [Homo sapiens] [gi:47496637] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | S100A4 [Homo sapiens] [gi:47496637] | | PubMed | | | Data Table |  |
|
| 34 | [SID56422573] | Inactive | Potency | | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 35 | [SID56422573] | Inactive | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 36 | [SID56422573] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] | | PubMed | | | Data Table |  |
|
| 37 | [SID56422573] | Inactive | Potency | | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 38 | [SID56422573] | Inactive | Potency | | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 39 | [SID56422573] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 40 | [SID56422573] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 41 | [SID56422573] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 42 | [SID56422573] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 43 | [SID56422573] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 44 | [SID56422573] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 45 | [SID56422573] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 46 | [SID56422573] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 47 | [SID56422573] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 48 | [SID56422573] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex [AID504707, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex | | AID | 504707 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] | | PubMed | | | Data Table |  |
|
| 49 | [SID56422573] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 50 | [SID56422573] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56422573 | | CID | 54693355 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|